CCL2 and hepatocellular carcinoma: In addition, CCL2 has proinflammatory, profibrotic, and proangiogenic effects in chronic liver disease and tumor-promoting effects in HCC, making it a potential drug target for the treatment of liver disease (13, 14, 16–18, 22, 23).